Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2
Closed -$521 262
2024
Q4
$521 Sell
2
-2
-50% -$593 ﹤0.01% 313
2024
Q3
$1.29K Hold
4
﹤0.01% 313
2024
Q2
$1.25K Hold
4
﹤0.01% 315
2024
Q1
$1.14K Hold
4
﹤0.01% 319
2023
Q4
$1.15K Buy
+4
New +$1.09K ﹤0.01% 313

Other funds holding AMGN

Fairman Group's AMGN Position: Q1 2025 in Review

Fairman Group sold out of Amgen (AMGN) in Q1 2025, closing a stake of 2 shares — an estimated $521 sold.

Fairman Group first reported a position in AMGN in Q4 2023 and held it in 5 quarters. The position peaked at $1.29K in Q3 2024. 2,927 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

  • Fairman Group reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
  • Fairman Group sold 2 Amgen shares in Q1 2025, an estimated $521.
  • Fairman Group first reported a position in Amgen in Q4 2023 and held it in 5 quarters.
  • Fairman Group's Amgen position peaked at $1.29K in Q3 2024.
  • 2,927 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on Fairman Group's 13F filing for Q1 2025, filed 7 May 2025.